Positive results from Phase IIb benralizumab study in severe asthma
|
10 October 2014 |
MedImmune and Cancer Research UK establish joint CRUK-MEDI Alliance Laboratory
|
25 September 2014 |
AstraZeneca and Lilly announce alliance to develop and commercialise BACE inhibitor AZD3293 for Alzheimer's disease
|
16 September 2014 |
AstraZeneca and Redx Pharma agree research collaboration
|
03 September 2014 |
New data indicates Brilinta/Brilique™ has the flexibility to be initiated pre-hospital or in hospital in STEMI patients
|
02 September 2014 |
United States Department of Justice closes investigation into PLATO clinical trial for Brilinta
|
19 August 2014 |
AstraZeneca agrees strategic transaction with Almirall in respiratory disease
|
30 July 2014 |
MedImmune and Advaxis partner on immuno-oncology combination clinical trial
|
22 July 2014 |
AstraZeneca reveals designs for new Global R&D Centre and Corporate Headquarters in Cambridge, UK
|
18 July 2014 |
AstraZeneca and Max Planck Institute announce research agreement
|
08 July 2014 |